Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-11-14 10:19 am Sale | 13G | Ambrx Biopharma Inc. AMAM | Deep Track Capital LP | 0 0.000% | -3,710,412 (Position Closed) | View |
2024-02-14 8:26 pm Purchase | 13G | Ambrx Biopharma Inc. AMAM | Venrock Healthcare Capital Partners III L.P. | 2,070,000 3.300% | 2,070,000 (New Position) | View |
2024-02-14 5:08 pm Purchase | 13G | Ambrx Biopharma Inc. AMAM | D. E. SHAW & CO L.P. | 4,240,486 6.700% | 4,240,486 (New Position) | View |
2024-02-14 4:08 pm Purchase | 13G | Ambrx Biopharma Inc. AMAM | Paradigm Biocapital Advisors LP | 4,502,689 7.100% | 4,502,689 (New Position) | View |
2024-02-14 4:05 pm Unchanged | 13G | Ambrx Biopharma Inc. AMAM | COMMODORE CAPITAL LP | 0 0.000% | 0 (Unchanged) | View |
2024-02-14 3:03 pm Purchase | 13G | Ambrx Biopharma Inc. AMAM | Cormorant Asset Management LP | 11,231,000 17.780% | 11,231,000 (New Position) | View |
2024-02-14 11:31 am Unchanged | 13G | Ambrx Biopharma Inc. AMAM | Deep Track Capital LP | 3,710,412 5.880% | 0 (Unchanged) | View |
2024-02-12 4:15 pm Purchase | 13G | Ambrx Biopharma Inc. AMAM | HOPU Reunion Co Ltd | 1,060,000 1.700% | 1,060,000 (New Position) | View |
2024-02-09 09:28 am Purchase | 13G | Ambrx Biopharma Inc. AMAM | FMR LLC | 1,474,258 2.334% | 1,474,258 (New Position) | View |
2024-02-05 4:15 pm Purchase | 13G | Ambrx Biopharma Inc. AMAM | WuXi PharmaTech Healthcare Fund I L.P. | 1,000,000 1.600% | 1,000,000 (New Position) | View |
2023-11-02 4:15 pm Purchase | 13G | Ambrx Biopharma Inc. AMAM | Nextech Crossover I GP S.a r.l. | 3,129,300 5.000% | 3,129,300 (New Position) | View |
2023-11-02 4:09 pm Purchase | 13G | Ambrx Biopharma Inc. AMAM | Deep Track Capital LP | 3,710,412 5.650% | 3,710,412 (New Position) | View |